{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=No+drug+will+be+used&page=12", "query": { "intervention": "No drug will be used", "page": 12 }, "page_size": 10 }, "pagination": { "page": 12, "page_size": 10, "total_count": 486, "total_pages": 49, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=No+drug+will+be+used&page=13&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=No+drug+will+be+used&page=11&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-15T23:49:59.896Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01996384", "title": "Provoked, Localized Vulvodynia Treatment With Acupuncture and Lidocaine Pilot Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Provoked, Localized Vulvodynia", "Provoked Vestibulodynia", "Vulvar Vestibulitis", "Vulvodynia" ], "interventions": [ { "name": "Classical Acupuncture", "type": "PROCEDURE" }, { "name": "Non-classical acupuncture", "type": "PROCEDURE" }, { "name": "Lidocaine", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Oregon College of Oriental Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 19, "start_date": "2013-11", "completion_date": "2016-03", "has_results": false, "last_update_posted_date": "2017-10-06", "last_synced_at": "2026-10-15T23:49:59.896Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT01996384" }, { "nct_id": "NCT04880304", "title": "Effects of Subconcussive Head Impacts on Neural Integrity and Function in ADHD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sport Injury", "Attention-deficit/Hyperactivity Disorder" ], "interventions": [ { "name": "Soccer Heading", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Indiana University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "26 Years", "sex": "ALL", "summary": "18 Years to 26 Years" }, "enrollment_count": 69, "start_date": "2021-03-15", "completion_date": "2022-03-15", "has_results": false, "last_update_posted_date": "2023-02-08", "last_synced_at": "2026-10-15T23:49:59.896Z", "location_count": 1, "location_summary": "Bloomington, Indiana", "locations": [ { "city": "Bloomington", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04880304" }, { "nct_id": "NCT04325802", "title": "Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis", "Pruritus", "Pruritus Chronic", "Dermatitis" ], "interventions": [ { "name": "Naltrexone", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 0, "start_date": "2022-12-31", "completion_date": "2024-06", "has_results": false, "last_update_posted_date": "2023-04-04", "last_synced_at": "2026-10-15T23:49:59.896Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04325802" }, { "nct_id": "NCT01863381", "title": "Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hydrocephalus", "Idiopathic Intracranial Hypertension", "Pseudotumor Cerebri" ], "interventions": [ { "name": "Tympanic membrane displacement (TMD)", "type": "DEVICE" }, { "name": "DPOAE", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "LifeBridge Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 5, "start_date": "2014-09", "completion_date": "2015-10", "has_results": false, "last_update_posted_date": "2017-08-11", "last_synced_at": "2026-10-15T23:49:59.896Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01863381" }, { "nct_id": "NCT05444751", "title": "GA + ESP vs. SA + ESP in Lumbar Decompression Surgeries", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lumbar Disc Herniation", "Lumbar Disc Disease", "Lumbar Radiculopathy" ], "interventions": [ { "name": "General anesthetic", "type": "DRUG" }, { "name": "SA + ESP", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hospital for Special Surgery, New York", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 142, "start_date": "2022-03-22", "completion_date": "2026-09", "has_results": false, "last_update_posted_date": "2026-04-28", "last_synced_at": "2026-10-15T23:49:59.896Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05444751" }, { "nct_id": "NCT03164057", "title": "A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Myeloid Leukemia", "Myelodysplastic Syndromes" ], "interventions": [ { "name": "Azacitidine", "type": "DRUG" }, { "name": "Decitabine", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Daunorubicin", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "ITMHA", "type": "COMBINATION_PRODUCT" }, { "name": "Idarubicin", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Mitoxantrone", "type": "DRUG" }, { "name": "Erwinia asparaginase", "type": "DRUG" }, { "name": "Sorafenib", "type": "DRUG" }, { "name": "G-CSF", "type": "DRUG" }, { "name": "Dexrazoxane", "type": "DRUG" }, { "name": "Stem Cell Transplant", "type": "BIOLOGICAL" }, { "name": "Asparaginase Erwinia Chrysanthemi, Recombinant-Rywn", "type": "DRUG" } ], "intervention_types": [ "DRUG", "COMBINATION_PRODUCT", "BIOLOGICAL" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "29 Days", "maximum_age": "21 Years", "sex": "ALL", "summary": "29 Days to 21 Years" }, "enrollment_count": 206, "start_date": "2017-06-15", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2026-04-23", "last_synced_at": "2026-10-15T23:49:59.896Z", "location_count": 10, "location_summary": "Madera, California • Orange, California • Palo Alto, California + 7 more", "locations": [ { "city": "Madera", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03164057" }, { "nct_id": "NCT06287151", "title": "Regional Anesthesia EMG Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Surgery" ], "interventions": [ { "name": "BlockSynop surface electromyography device", "type": "DEVICE" }, { "name": "Clonidine", "type": "DRUG" }, { "name": "Sevoflurane", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Nationwide Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": "5 Years", "sex": "ALL", "summary": "0 Years to 5 Years" }, "enrollment_count": 80, "start_date": "2023-08-09", "completion_date": "2025-02-28", "has_results": false, "last_update_posted_date": "2026-08-06", "last_synced_at": "2026-10-15T23:49:59.896Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06287151" }, { "nct_id": "NCT06573970", "title": "Atomoxetine and Executive Function in PTSD", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Posttraumatic Stress Disorder With Attention Defic" ], "interventions": [ { "name": "Atomoxetine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 160, "start_date": "2026-04-01", "completion_date": "2029-09-28", "has_results": false, "last_update_posted_date": "2026-07-07", "last_synced_at": "2026-10-15T23:49:59.896Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06573970" }, { "nct_id": "NCT04125186", "title": "A Cross-Functional, Population-Representative, Web-Based, Epidemiologic Study to Estimate the Prevalence and Burden of Nocturia Due to Nocturnal Polyuria in the US", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Nocturnal Polyuria" ], "interventions": [ { "name": "Baseline EpiNP survey", "type": "DIAGNOSTIC_TEST" }, { "name": "Bladder diary", "type": "DIAGNOSTIC_TEST" }, { "name": "Testing of EpiNP baseline survey, bladder diary and a qualitative interview", "type": "DIAGNOSTIC_TEST" }, { "name": "No other intervention", "type": "OTHER" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "Ferring Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 10190, "start_date": "2019-07-22", "completion_date": "2020-06-30", "has_results": false, "last_update_posted_date": "2023-03-13", "last_synced_at": "2026-10-15T23:49:59.896Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT04125186" }, { "nct_id": "NCT04606420", "title": "Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alzheimer Disease" ], "interventions": [ { "name": "Lifestyle medicine", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Preventive Medicine Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "45 Years to 90 Years" }, "enrollment_count": 51, "start_date": "2018-09-08", "completion_date": "2023-09-30", "has_results": false, "last_update_posted_date": "2022-09-15", "last_synced_at": "2026-10-15T23:49:59.896Z", "location_count": 4, "location_summary": "San Diego, California • Sausalito, California • Boston, Massachusetts + 1 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Sausalito", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Reno", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT04606420" } ] }